Cited by 380Mental Health Treatment and AccessWorkplace Health and Well-beingTreatment of Major Depression

Employer burden of mild, moderate, and severe major depressive disorder: mental health services utilization and costs, and work performance

Birnbaum, Howard G., Kessler, Ronald C., Kelley, David, Ben-Hamadi, Rym, Joish, Vijay N., Greenberg, Paul E.·2010·Depression and Anxiety

Abstract

BACKGROUND: Treatment utilization/costs and work performance for persons with major depressive disorder (MDD) by severity of illness is not well documented. METHODS: Using National Comorbidity Survey-Replication (2001-2002) data, US workforce respondents (n=4,465) were classified by clinical severity (not clinically depressed, mild, moderate, severe) using a standard self-rating scale [Quick Inventory of Depressive Symptomatology Self-Report (QIDS-SR)]. Outcomes included 12-month prevalence of medical services/medications use/costs and workplace performance. Treatment costs (employer's perspective) were estimated by weighing utilization measures by unit costs obtained for similar services used by MDD patients in claims data. Descriptive analysis across three severity groups generated chi(2) results. RESULTS: Using a sample of 539 US workforce respondents with MDD, 13.8% were classified mild, 38.5% moderate, and 47.7% severe cases. Mental health services usage, including antidepressants, increased significantly with severity, with average treatment costs substantially higher for severe than for mild cases both regarding mental health services ($697 vs. $388, chi(2)=4.4, P=.019) and antidepressants ($256 vs. $88, chi(2)=9.0, P=.001). Prevalence rates of unemployment/disability increased significantly (chi(2)=11.7, P=.003) with MDD severity (15.7, 23.3, and 31.3% for mild, moderate, and severe cases). Severely and moderately depressed workers missed more work than nondepressed workers; the monthly salary-equivalent lost performance of $199 (severely depressed) and $188 (moderately depressed) was significantly higher than for nondepressed workers (chi(2)=10.3, P<.001). Projected to the US workforce, monthly depression-related worker productivity losses had human capital costs of nearly $2 billion. CONCLUSIONS: MDD severity is significantly associated with increased treatment usage/costs, treatment adequacy, unemployment, and disability and with reduced work performance.

Integrity signals

Registry

Crossref · 10.1002/da.20580

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Only a minority of people with major depressive disorder receive treatment.

    “Although effectiveness trials show that expanded MDD treatment can reverse many of these adverse effects, only a minority of people with MDD receives treatment and the quality of treatment is unacceptably low among the majority of those in treatment.”

    From The Costs of Depression (2012) · cites this paper as [132]

  • The quality of treatment for major depressive disorder is low for most people who receive it.

    “Although effectiveness trials show that expanded MDD treatment can reverse many of these adverse effects, only a minority of people with MDD receives treatment and the quality of treatment is unacceptably low among the majority of those in treatment.”

    From The Costs of Depression (2012) · cites this paper as [132]

  • Stress, depression, and anxiety among working populations can result in reduced work performance and increased absenteeism.

    “Work-related stress, depression, and anxiety can result in reduced work performance and absenteeism [3-7]”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Birnbaum, H. G., Kessler, R. C., Kelley, D., Ben-Hamadi, R., Joish, V. N., & Greenberg, P. E.
Affiliations
  • Analysis Group (United States) (US)
  • Harvard University (US)
  • Sanofi (United States) (US)
Corresponding author
Birnbaum, Howard G.
Venue
Depression and Anxiety
Published
2010-01
Volume
27
Issue
1
Pages
78-89
ISSN
  • 1091-4269 (ISSN-L)
  • 1520-6394
OpenAlex
W1971486864
Cited by
380
References
24
Citations by year
2026: 5 · 2025: 13 · 2024: 15 · 2023: 17 · 2022: 26 · 2021: 38 · 2020: 29 · 2019: 26 · 2018: 40 · 2017: 30 · 2016: 20 · 2015: 32 · 2014: 22 · 2013: 31 · 2012: 14
FWCI
14.80
Type
journal article
Language
en
Open access
closed
Locations
  • Depression and Anxiety (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute of Mental Health (U01-MH-60220, U01MH060220)
Topics
  • Social Sciences › Psychology › Social Psychology › Mental Health Treatment and Access
  • Health Sciences › Health Professions › General Health Professions › Workplace Health and Well-being
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
Keywords
major depressive disorder, depression severity, employer burden, mental health service utilization, treatment costs, antidepressants, employee performance, productivity loss, unemployment, disability, human capital costs, labor force
MeSH terms
Absenteeism, Adolescent, Adult, Costs and Cost Analysis, Cross-Sectional Studies, Depressive Disorder, Major, Major Depressive Disorder, Employee Performance Appraisal, Health Expenditures, Female, Health Surveys, Humans, Male, Mental Health Services, Middle Aged, Occupational Diseases, United States, Utilization Review, Cost of Illness, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review